14-day Premium Trial Subscription Try For FreeTry Free
$0.143
+0.0040 (+2.88%)
At Close: May 17, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2023 ended December 31, 2022 and Provides Conference Call Information

 05:07pm, Tuesday, 14'th Feb 2023
Conference Call Scheduled for Wednesday, February 15 at 11:30 AM EST NORTHVALE, NJ / ACCESSWIRE / February 14, 2023 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty p

Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2023 Financial Results on February 15, 2023

 07:00am, Wednesday, 08'th Feb 2023
Financials for Third Quarter Fiscal Year 2023 Ended December 31, 2022 will be released on February 14, 2023 NORTHVALE, NJ / ACCESSWIRE / February 8, 2023 / Elite Pharmaceuticals, Inc. ("Elite" or the

Elite Pharmaceuticals, Inc. (ELTP) Q2 2023 Earnings Call Transcript

 01:42pm, Tuesday, 15'th Nov 2022
Elite Pharmaceuticals, Inc. (OTCQB:ELTP) Q2 2023 Earnings Conference Call November 15, 2022 11:30 AM ET Company Participants Nasrat Hakim – President and Chief Executive Officer Robert Chen – Chie

Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2023 Ended September 30, 2022 and Provides Conference Call Information

 11:30am, Tuesday, 15'th Nov 2022
Conference Call Scheduled for Tuesday, November 15 at 11:30 AM EST NORTHVALE, NJ / ACCESSWIRE / November 15, 2022 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company")(OTCQB:ELTP), a specialty phar

Elite Pharmaceuticals, Inc. (ELTP) CEO Nasrat Hakim on Q1 2023 Results - Earnings Call Transcript

 02:30pm, Tuesday, 16'th Aug 2022
Elite Pharmaceuticals, Inc. (OTCQB:ELTP) Q1 2023 Earnings Conference Call August 16, 2022 11:30 AM ET Company Participants Nasrat Hakim - President and Chief Executive Officer Robert Chen - Chief Fina

Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2023 ended June 30, 2022, and Provides Conference Call Information

 04:55pm, Monday, 15'th Aug 2022
Conference Call Scheduled for Tuesday, August 16 at 11:30 AM EDT NORTHVALE, NJ / ACCESSWIRE / August 15, 2022 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company")(OTCQB:ELTP), a specialty pharmace

Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss First Quarter 2023 Financial Results on August 16, 2022

 07:00am, Thursday, 11'th Aug 2022
Financials for First Quarter Fiscal Year 2023 Ended June 30, 2022 will be released on August 15, 2022 NORTHVALE, NJ / ACCESSWIRE / August 11, 2022 / Elite Pharmaceuticals, Inc. ("Elite" or the "Compan

Elite Pharmaceuticals, Inc.'s (ELTP) CEO Nasrat Hakim on Q4 2022 Results - Earnings Call Transcript

 05:39pm, Thursday, 30'th Jun 2022
Elite Pharmaceuticals, Inc. (OTCQB:ELTP) Q4 2022 Earnings Conference Call June 30, 2022 11:30 AM ET Company Participants Nasrat Hakim - President and CEO Robert Chen - Chief Financial Officer Dianne W

Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2022 and Provides Conference Call Information

 04:55pm, Wednesday, 29'th Jun 2022
Conference Call Scheduled for Thursday, June 30 at 11:30 AM EDT NORTHVALE, NJ / ACCESSWIRE / June 29, 2022 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceut

Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Fiscal Year 2022 Financial Results on June 30, 2022

 04:30pm, Thursday, 23'rd Jun 2022
Financials for Fiscal Year 2022 Ended March 31, 2022 will be released on June 29, 2022 NORTHVALE, NJ / ACCESSWIRE / June 23, 2022 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP),

Elite Pharmaceuticals, Inc. (ELTP) CEO Nasrat Hakim on Q3 2022 Results - Earnings Call Transcript

 02:11pm, Tuesday, 15'th Feb 2022
Elite Pharmaceuticals, Inc. (ELTP) CEO Nasrat Hakim on Q3 2022 Results - Earnings Call Transcript
...

Elite Pharmaceuticals GAAP EPS of $0.00, revenue of $8.97M

 05:52am, Tuesday, 15'th Feb 2022 Seeking Alpha
Elite Pharmaceuticals press release (ELTP): FQ3 GAAP EPS of $0.00.Revenue of $8.97M (+48.3% Y/Y).10Q

Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year Ended December 31, 2021 and Provides Conference Call Information

 06:25pm, Monday, 14'th Feb 2022
Conference Call Scheduled for Tuesday, February 15 at 11:30 AM EST NORTHVALE, NJ / ACCESSWIRE / February 14, 2022 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company")(OTCQB:ELTP), a specialty phar

Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2022 Financial Results on February 15, 2022

 05:15pm, Wednesday, 09'th Feb 2022
Financials for Third Quarter Fiscal Year 2022 Ended December 31, 2021 will be released February 14, 2022 NORTHVALE, NJ / ACCESSWIRE / February 9, 2022 / Elite Pharmaceuticals, Inc. ("Elite" or the "Co

Elite Pharmaceuticals, Inc. (ELTP) CEO Nasrat Hakim on Q2 2022 Results - Earnings Call Transcript

 04:45pm, Tuesday, 16'th Nov 2021
Elite Pharmaceuticals, Inc. (ELTP) CEO Nasrat Hakim on Q2 2022 Results - Earnings Call Transcript
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE